Matches in Nanopublications for { ?s ?p "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP227914.RAnIUymptsAsvTh_yHH8MgSaZxvstH3aibldpiOvyXXsc130_assertion description "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227914.RAnIUymptsAsvTh_yHH8MgSaZxvstH3aibldpiOvyXXsc130_provenance.
- NP908835.RAVWZB8DqMWBZSd9Qkm_AvfRt1DcXRgU4uvrR4zb2Qy7E130_assertion description "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP908835.RAVWZB8DqMWBZSd9Qkm_AvfRt1DcXRgU4uvrR4zb2Qy7E130_provenance.
- NP483867.RAG_GRfaFOABS_r_BjvtqmsgjJYe1a0k2gun-0S6_s9MA130_assertion description "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483867.RAG_GRfaFOABS_r_BjvtqmsgjJYe1a0k2gun-0S6_s9MA130_provenance.
- NP796604.RAOBj-ata3maMLN5JNhxEqOrxbQtV5XpUfBKNU1zXbg8Q130_assertion description "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796604.RAOBj-ata3maMLN5JNhxEqOrxbQtV5XpUfBKNU1zXbg8Q130_provenance.